Recruiting The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-center, Open-label Cohort Study NCT07464366 Conditions Salivary Gland Carcinomas Locations Fudan University Shanghai Cancer Center — Shanghai, Shanghai Municipality, China View Trial Details
Recruiting VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228 Conditions Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +65 more Locations Providence Medical Foundation (site 209) — Santa Rosa, California, United States Hartford Hospital (site 210) — Hartford, Connecticut, United States The George Washington University Cancer Center (site 212) — Washington D.C., District of Columbia, United States Holy Cross Hospital (site 213) — Fort Lauderdale, Florida, United States View all 15 locations View more locations Show fewer locations Loading locations... View Trial Details
